IP under threat from competition clampdown

From pharmaceuticals to telecoms, software and even copyright licensing, antitrust authorities are clamping down on abuses of IP rights. James Nurton, Eileen McDermott and Peter Ollier examine why IP is under scrutiny and discuss some pending cases and investigations
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article: